MDA-7/IL-24 also acted synergistically in colorectal cancer and prostate cancer cells when combined with the Apogossypol derivatives, BI-97C1 and BI-97D6, which are pharmacological inhibitors of Mcl-1 [94,112,114]. This evidence concerns the gene IL24 and prostate carcinoma.